Actinic (Solar) Keratosis Treatment Market By Treatment type ( Photodynamic therapy, Topical treatments, Surgical procedures, Combination therapy ), By End-user ( Clinics, Hospitals, Oncology centers, Dermatology service centers ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Actinic (solar) keratosis Treatment Market is expected to grow with a CAGR of 4.8% during the forecast period of 2018 to 2025.
  • Market Overview:

    Actinic keratosis or solar keratosis is a pre-cancerous skin disorder that is mainly caused due to the constant exposure of skin to UVB radiation. It is most prevalent in people above the age of 50 years, however, people at the age of 20 years are also prone to such skin disorders. The chances of actinic keratosis developing into a squamous cell skin cancer is at a rate of nearly 20%, if left untreated. People living near to the equator and having constant exposure to sun are the most likely to suffer from solar keratosis. According to the Skin Cancer Foundation, actinic keratosis is the most common type of pre-cancer disorder that affects nearly 58 million people in America.

    Moreover, approximately $3.3 billion are spent annually for treating melanoma skin cancer in the U.S. Owing to such notable statistics, the global actinic keratosis treatment market is expected to grow at a significant rate of 4.8% per year. In addition, prominent market players are focusing on merger & acquisitions, partnerships, product launch, and expansion, in order to uplift the global market and gain a competitive edge over their counterparts. However, the lack of awareness regarding actinic keratosis treatments and it’s carcinogenic developments if left untreated, are expected to hinder the growth of the market.

    The report provides detailed qualitative and quantitative analysis of the global actinic (solar) keratosis treatment market. Market size and forecast in terms of value has been provided for the period – (2017 – 2025), for the segments namely treatment type, and end-user in each of the major regions of the world.

    Actinic (Solar) Keratosis Treatment Market Segmentation

    By Treatment type

    • Photodynamic therapy
    • Topical treatments
    o Diclofenac gel
    o Imiquimod cream
    o Fluorouracil cream
    o Ingenol mebutate gel
    o Others
    • Surgical procedures
    o Curettage and desiccation
    o Laser surgery
    o Dermabrasion
    o Cryosurgery
    • Combination therapy

    By End-user
    • Clinics
    • Hospitals
    • Oncology centers
    • Dermatology service centers
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

     • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET OVERVIEW
    2.1. ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET INTRODUCTION
    2.2. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.2.1. Global Actinic (Solar) Keratosis Treatment Market Revenue (Million USD) and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET BY TREATMENT TYPE, 2017-2025
    3.1. PHOTODYNAMIC THERAPY
    3.2. TOPICAL TREATMENTS
    3.2.1. DICLOFENAC GEL
    3.2.2. IMIQUIMOD CREAM
    3.2.3. FLUOROURACIL CREAM
    3.2.4. INGENOL MEBUTATE GEL
    3.3. SURGICAL PROCEDURES
    3.2.1. CURETTAGE AND DESICCATION
    3.2.2. LASER SURGERY
    3.2.3. DERMABRASION
    3.2.3. CRYOSURGERY
    3.4. COMBINATION THERAPY
    3.5. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET REVENUE BY TREATMENT TYPE, 2017-2025
    3.5.1. Global Actinic (Solar) Keratosis Treatment Market Revenue (Million USD) and Share (%) By Treatment type, 2017-2025
    3.5.2. Photodynamic therapy Market Revenue and Growth Rate, 2017-2025
    3.5.3. Topical treatments Market Revenue and Growth Rate, 2017-2025
    3.5.4. Surgical procedures Market Revenue and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other treatment type segment and each of the sub-segments.

    CHAPTER 4. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET BY APPLICATION, 2017-2025
    4.1. DERMATOLOGY SERVICE CENTERS
    4.2. HOSPITALS
    4.3. ONCOLOGY CENTERS
    4.4. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Actinic (Solar) Keratosis Treatment Market Revenue (Million USD) and Share (%) By Application, 2017-2025 20
    4.4.2. Dermatology service centers Market Revenue and Growth Rate, 2017-2025
    4.4.3. Hospitals Market Revenue and Growth Rate, 2017-2025
    4.4.4. Oncology centers Market Revenue and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other application segment.

    CHAPTER 5. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Actinic (Solar) Keratosis Treatment Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. MARKET DETERMINANTS
    6.1. MARKET DRIVERS
    6.2. MARKET RESTRAINTS
    6.3. MARKET OPPORTUNITIES
    6.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 7. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET COMPETITION BY SERVICE PROVIDERS
    7.1. GLOBAL ACTINIC (SOLAR) KERATOSIS TREATMENT REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
    7.1.1. Global Actinic (Solar) Keratosis Treatment Revenue (Million USD) and Share (%) by Service Providers (2017-2025)
    7.2. ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET COMPETITIVE SITUATION AND TRENDS
    7.2.1. Actinic (Solar) Keratosis Treatment Market Share (%) of Top 3 Service Providers
    7.2.2. Actinic (Solar) Keratosis Treatment Market Share (%) of Top 5 Service Providers

    CHAPTER 8. COMPANY PROFILES
    8.1. DUSA PHARMACEUTICALS INC.
    8.1.1. Business Overview
    8.1.2. Company Basic Information
    8.1.3. Actinic (Solar) Keratosis Treatment Product Details
    8.1.4. DUSA Pharmaceuticals Inc. Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.2. LEO PHARMA INC.
    8.2.1. Business Overview
    8.2.2. Company Basic Information
    8.2.3. Actinic (Solar) Keratosis Treatment Product Details
    8.2.4. LEO Pharma Inc. Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.3. CLINUVEL PHARMACEUTICALS LTD
    8.3.1. Business Overview
    8.3.2. Company Basic Information
    8.3.3. Actinic (Solar) Keratosis Treatment Product Details
    8.3.4. Clinuvel Pharmaceuticals Ltd Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.4. VALEANT
    8.4.1. Business Overview
    8.4.2. Company Basic Information
    8.4.3. Actinic (Solar) Keratosis Treatment Product Details
    8.4.4. Valeant Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.5. BIOFRONTERA AG
    8.5.1. Business Overview
    8.5.2. Company Basic Information
    8.5.3. Actinic (Solar) Keratosis Treatment Product Details
    8.5.4. Biofrontera AG Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.6. GALDERMA S.A.
    8.6.1. Business Overview
    8.6.2. Company Basic Information
    8.6.3. Actinic (Solar) Keratosis Treatment Product Details
    8.6.4. Galderma S.A. Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.7. PERRIGO COMPANY PLC
    8.7.1. Business Overview
    8.7.2. Company Basic Information
    8.7.3. Actinic (Solar) Keratosis Treatment Product Details
    8.7.4. Perrigo Company plc Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.8. TOLMAR PHARMACEUTICALS INC.
    8.8.1. Business Overview
    8.8.2. Company Basic Information
    8.8.3. Actinic (Solar) Keratosis Treatment Product Details
    8.8.4. TOLMAR Pharmaceuticals Inc. Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.9. 3M DRUG DELIVERY SYSTEMS
    8.9.1. Business Overview
    8.9.2. Company Basic Information
    8.9.3. Actinic (Solar) Keratosis Treatment Product Details
    8.9.4. 3M Drug Delivery Systems Actinic (Solar) Keratosis Treatment Revenue and Gross Margin
    8.10. ATHENEX INC
    8.10.1. Business Overview
    8.10.2. Company Basic Information
    8.10.3. Actinic (Solar) Keratosis Treatment Product Details
    8.10.4. Athenex Inc Actinic (Solar) Keratosis Treatment Revenue and Gross Margin

    CHAPTER 9. ACTINIC (SOLAR) KERATOSIS TREATMENT MARKET VALUE CHAIN ANALYSIS
    9.1. ACTINIC (SOLAR) KERATOSIS TREATMENT INDUSTRIAL CHAIN ANALYSIS
    9.2. MARKETING CHANNEL
    9.2.1. Direct Marketing
    9.2.2. Indirect Marketing
    9.2.3. Distributors/Traders
    9.3. CONSUMER ANALYSIS
    9.3.1. Consumer 1
    9.3.2. Consumer 2
    9.3.3. Consumer 3
    9.3.4. Consumer 4

    keyboard_arrow_up
  • • LEO Pharma Inc.
    • DUSA Pharmaceuticals Inc.
    • Clinuvel Pharmaceuticals Ltd
    • Valeant
    • Biofrontera AG
    • Galderma S.A.
    • Perrigo Company plc
    • TOLMAR Pharmaceuticals Inc.
    • 3M Drug Delivery Systems
    • Athenex Inc
    • CritiTech Inc
    • Foamix Pharmaceuticals Ltd
    • G&E Herbal Biotechnology Co Ltd
    • Novartis AG
    • Oncology Research International Ltd

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Actinic (Solar) Keratosis Treatment Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Actinic (Solar) Keratosis Treatment Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

You may also like

CLIENTS

SHARE YOUR CART